CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
diet, reducing +2 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000519
NCT00000519Phase 3Completed
CompareCT.gov

Exercise Training and Plasma Lipoproteins in Man

Stanford University·interventional·Posted Oct 28, 1999·Updated Jun 26, 2013

In Brief

A Phase 3 clinical trial evaluating diet, reducing, exercise, and 1 other intervention for Cardiovascular Diseases and 5 related conditions. Completed.

Detailed Summary

To determine the effects in moderately obese subjects of weight loss by combined dieting and exercise training on risk factors for coronary artery disease including lipoprotein lipids, apoproteins and blood pressure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Coronary Disease, Heart Diseases, Hypertension, Myocardial Ischemia, Obesity
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

Phase 3CompletedFinished
1982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartJul 1, 1982
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

diet, reducingbehavioral

exercisebehavioral

diet, fat-restrictedbehavioral